Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 4/20 | 0.89 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.89 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.56 |
| ▸ | KDR | P35968 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL316126 | 1.00 | CXCR4 (0.89) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL623920 | 1.00 | — | — | |
| SCHEMBL11232630 | 1.00 | CXCR4 (0.89) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL11235838 | 1.00 | CXCR4 (0.89) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL577659 | 0.94 | CXCR4 (1.00) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL576838 | 0.94 | CXCR4 (1.00) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL3632859 | 0.94 | CXCR4 (0.80) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL22199 | 0.94 | CXCR4 (1.00) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL9947670 | 0.94 | CXCR4 (1.00) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT | |
| SCHEMBL8503965 | 0.94 | CXCR4 (1.00) | CXCR4SMN1; SMN2ALDH1A1HIF1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719486-A1 | CONJUGATES AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| EP-4719498-A1 | RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF | Full-Life Technologies UK Limited (GB) | 2026-04-08 | — | — | EP | claimed |
| WO-2025199636-A1 | TARGETED RADIOLIGAND COMPOUNDS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2025-10-02 | — | — | WO | claimed |
| EP-4619411-A1 | DUAL RECEPTOR TARGETING RADIOLIGANDS AND USES THEREOF | Full-Life Technologies HK Limited (HK) | 2025-09-24 | — | — | EP | claimed |
| CN-120129690-A | Dual receptor targeted radioligands and uses thereof | 辐联科技香港有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-4556029-A2 | RADIOPHARMACEUTICAL CONJUGATE | The South African Nuclear Energy Corporation Limited (ZA) | 2025-05-21 | — | — | EP | claimed |
| US-20250099632-A1 | CLEAVABLE RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF | FULL-LIFE TECHNOLOGIES UK LIMITED (GB) | 2025-03-27 | — | — | US | claimed |
| CN-119565397-A | High-flux high-chemical-resistance composite nanofiltration membrane and preparation method and application thereof | 万华化学集团股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| US-20250026739-A1 | COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF | FULL-LIFE TECHNOLOGIES HK LIMITED (CN) | 2025-01-23 | — | — | US | claimed |
| EP-4479040-A1 | COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF | Full-Life Technologies HK Limited (HK) | 2024-12-25 | — | — | EP | claimed |
| US-20120213698-A1 | LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE CONTAINING NANOPARTICLES | RIGSHOSPITALET (DK) | 2012-08-23 | — | — | US | claimed |
| EP-2399938-A2 | Peptide purification by means of hard metal ion affinity chromatography | Novo Nordisk A/S (DK) | 2011-12-28 | — | — | EP | claimed |
| US-20090143529-A1 | Peptide purification by means of hard metal ion affinity chromatography | HEARN MILTON THOMAS WILLIAM | 2009-06-04 | — | — | US | claimed |
| US-7452845-B2 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-11-18 | — | — | US | claimed |
| EP-1370563-B1 | MESOPOROUS ORGANIC-INORGANIC HYBRID MATERIALS FOR SEPARATING GASES | CENTRE NAT RECH SCIENT (FR) | 2006-09-06 | — | — | EP | claimed |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | CENTRE NATIONAL DE LA RECHERCHE-SCIENTIFIQUE (FR) | 2004-06-24 | — | — | US | claimed |
| EP-0325307-B1 | MACROCYCLIC POLYAMINE MULTIFUNCTIONAL LUBRICATING OIL ADDITIVES | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1993-02-03 | — | — | EP | claimed |
| EP-0325307-A2 | Macrocyclic polyamine multifunctional lubricating oil additives | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1989-07-26 | — | — | EP | claimed |
| EP-0113582-A2 | Macrocyclic polyamine and polycyclic polyamine multifunctional lubricating oil additives | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-07-18 | — | — | EP | claimed |
| US-4001212-A | EXTRACT METAL IONS FROM SOLUTION AND COMPLEX | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-01-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026739-A1 | COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF | NTSR1, NTSR2, NPSR1 | CXCR4 447/4885SMN1; SMN2 1239/4885ALDH1A1 3833/4885 |
| US-20040122250-A1 | Mesoporous organic-inorganic hybrid materials for separating gases | SCO2, IPO9, IPO4 | CXCR4 1677/4885SMN1; SMN2 2963/4885ALDH1A1 4090/4885 |
| US-20250099632-A1 | CLEAVABLE RADIOLIGANDS FOR TARGETING CELL SURFACE RECEPTORS AND USES THEREOF | ASGR1, GNRHR, SCTR | CXCR4 641/4885SMN1; SMN2 3813/4885ALDH1A1 3790/4885 |
| US-20090143529-A1 | Peptide purification by means of hard metal ion affinity chromatography | MAX, PTMS, SLC7A1 | CXCR4 1801/4885SMN1; SMN2 3612/4885ALDH1A1 4834/4885 |
| US-20120213698-A1 | LOADING TECHNIQUE FOR PREPARING RADIONUCLIDE CONTAINING NANOPARTICLES | LIPG, NPC1L1, CD47 | CXCR4 790/4885SMN1; SMN2 4425/4885ALDH1A1 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.